Trastuzumab Labeled to High Specific Activity with 111In by Conjugation to G4 PAMAM Dendrimers Derivatized with Multiple DTPA Chelators Exhibits Increased Cytotoxic Potency on HER2-Positive Breast Cancer Cells

The Effect of Metal-Chelating Polymers (MCPs) for 111In Complexed via the Streptavidin-Biotin System to Trastuzumab Fab Fragments on Tumor and Normal Tissue Distribution in Mice

(2012) Amanda J. Boyle et al.   PHARMACEUTICAL RESEARCH

Antitumor Effects and Normal-Tissue Toxicity of 111In-Nuclear Localization Sequence-Trastuzumab in Athymic Mice Bearing HER-Positive Human Breast Cancer Xenografts

(2010) D. L. Costantini et al.   JOURNAL OF NUCLEAR MEDICINE

Cellular Dosimetry of 111In Using Monte Carlo N-Particle Computer Code: Comparison with Analytic Methods and Correlation with In Vitro Cytotoxicity

(2010) Z. Cai et al.   JOURNAL OF NUCLEAR MEDICINE

Anionic Amino Acid Dendrimer−Trastuzumab Conjugates for Specific Internalization in HER2-Positive Cancer Cells

(2010) Takuya Miyano et al.   MOLECULAR PHARMACEUTICS

111In- or 99mTc-labeled recombinant VEGF bioconjugates: in vitro evaluation of their cytotoxicity on porcine aortic endothelial cells overexpressing Flt-1 receptors

(2009) Conrad Chan et al.   NUCLEAR MEDICINE AND BIOLOGY

Antibody−Dendrimer Conjugates: The Number, Not the Size of the Dendrimers, Determines the Immunoreactivity

(2008) C. Wängler et al.   BIOCONJUGATE CHEMISTRY

Update: Peptide Motifs for Insertion of Radiolabeled Biomolecules into Cells and Routing to the Nucleus for Cancer Imaging or Radiotherapeutic Applications

(2008) Danny L. Costantini et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts

(2008) Kristin McLarty et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Relationship Between Induction of Phosphorylated H2AX and Survival in Breast Cancer Cells Exposed to 111In-DTPA-hEGF

(2008) Z. Cai et al.   JOURNAL OF NUCLEAR MEDICINE